Emily Field

Barclays Head of Equity Research, US Biopharmaceuticals
· tracked since Aug 2026
Calls
1
Win Rate
100.0%
return
+0.1%
Calls 1 1 Posts tracked · 1.0/day Posted today
Calls
7d 1
30d 1
90d 1
Best Calls
LLY Long +0.1%
Worst Calls
No live losers yet
Most Mentioned
LLY ×1
Recent Calls
LLY Long 9 hours ago
Win Rate 100% Long 1 Short 0
Win Rate
7d —
30d —
90d —
Average Return +0.1% Long Return +0.1% Short Return -
Average Return
7d —
30d —
90d —
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
LLY Eli Lill... Eli Lilly and Company
Long
Aug 05
$1173.00
+0.1%
Eli Lilly obesity drugs still early growth
Eli Lilly's obesity and diabetes drugs delivered a strong beat with penetration still in low single digits globally, indicating a long structural growth opportunity; pricing pressures are offset by volume uptake, keeping revenue growth robust.
GLP-1 / Obesity
YOUTUBE
Showing 1 of 1 calls · sorted by mentions

Emily Field has 1 trade ideas tracked on Buzzberg across 1 tickers since August 2026. Most covered: LLY.